Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell–dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells-Reference-Cited by-同舟云学术

Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell–dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells

Published:2017-02 Issue:2 Volume:91 Page:477-492
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Shiu Kin Yee,McLaughlin Laura,Rebollo-Mesa Irene,Zhao Jingyue,Burton Hannah,Douthwaite Harriet,Wilkinson Hannah,Semik Vikki,Dodd Philippa C.,Brookes Paul,Lechler Robert I.,Hernandez-Fuentes Maria P.,Kemper Claudia,Dorling Anthony

Publisher

Elsevier BV

Subject

Nephrology

Reference47 articles.

1. Economic evaluation of end stage renal disease treatment;de Wit;Health Policy,1998

2. The cost-effectiveness of increasing kidney transplantation and home-based dialysis;Howard;Nephrology (Carlton),2009

3. Long-term renal allograft survival in the United States: a critical reappraisal;Lamb;Am J Transplant,2011

4. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure;Gaston;Transplantation,2010

5. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts;Lachmann;Transplantation,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection;Transplant International;2024-08-20

2. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases;The FASEB Journal;2024-03-12

3. Regulatory B Cells—Immunopathological and Prognostic Potential in Humans;Cells;2024-02-18

4. Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy;Transplantation;2023-10-02

5. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases;2023-09-25